Angene Chemical
Draw
|
Currency :
Home Products

AG00FDV7

684286-46-2 | cis-Glimepiride

Chemical structure of cis-Glimepiride, CAS 684286-46-2
AG00FDV7
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 684286-46-2
Catalog Number AG00FDV7(AGN-PC-0TSJ4C)
Chemical Name cis-Glimepiride
IUPAC Name 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
InChI InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)
InChI Key WIGIZIANZCJQQY-UHFFFAOYSA-N
MDL Number MFCD21363627
Molecular Formula C24H34N4O5S
Molecular Weight 490.6156
NSC Number 759809
SMILES CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C
Synonyms
1-(4-(2-(3-ethyl-4-methyl-2-oxo-3-pyrrolinecarboxamido)ethyl)phenylsulfonyl)-3-(4-methylcyclohexyl)urea, Amarel, Amaryl, glimepiride, glymepiride, HOE 490, HOE-490, Roname, glimepiride, 93479-97-1, Amaryl, Glimepiridum, Glimepirida, Amarel, Glimepirid, Endial, Glimepride, Hoe-490, Glimepiridum [Latin], HOE 490, Glimepirida [Spanish], Glista OD, GLIMPERIDE, cis-Glimepiride, UNII-24T6XIR2MZ, CCRIS 7083, 684286-46-2, UNII-6KY687524K, 1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea, BRN 5365754, 24T6XIR2MZ, CHEBI:5383, MFCD00878417, 6KY687524K, 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide, NCGC00016960-03, CPD000466368, Roname, CAS-93479-97-1, DSSTox_CID_20675, DSSTox_RID_79534, DSSTox_GSID_40675, 3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, Glymepirid, Glorion, Glemax, Glimer, Solosa, Novo-glimepiride, PMS-glimepiride, Ratio-glimepiride, Sandoz glimepiride, Glimepiride, cis-, 1H-Pyrrole-1-carboxamide, 2,5-dihydro-3-ethyl-4-methyl-N-(2-(4-(((((4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-, trans-, 1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-(2-(4-(((((4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-, trans-, 3-Ethyl-4-Methyl-N-[2-(4-{[(Cis-4-Methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-Oxo-2,5-Dihydro-1h-Pyrrole-1-Carboxamide, SMR000466368, Amaryl (TN), Glimepiride [USAN:BAN:INN], SR-05000001508, gimepiride, Sugral, Amary, HOE490, Vitaimin E, Glimepiride,(S), 1-[[P-[2-(3-ETHYL-4-METHYL-2-OXO-3-PYRROLINE-1-CARBOXAMIDO)ETHYL]PHENYL]SULFONYL]-3-(TRANS-4-METHYLCYCLOHEXYL)UREA, 3-ethyl-4-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-2-oxo-5H-pyrrole-1-carboxamide, Glimepiride [USAN:USP:INN:BAN], Prestwick0_000651, Prestwick1_000651, Prestwick2_000651, Prestwick3_000651, AC1L1G0T, CHEMBL1481, Oprea1_382896, SCHEMBL16084, SCHEMBL16086, BSPBio_000681, MLS000759495, MLS001076674, MLS001401419, MLS003915622, MLS006011260, SPBio_002602, BPBio1_000751, CHEMBL149223, GTPL6820, SCHEMBL8738802, Glimepiride (JP17/USP/INN), DTXSID5040675, SCHEMBL14371714, SCHEMBL14965363, CHEBI:92609, CTK8E7555, AOB5663, WIGIZIANZCJQQY-RUCARUNLSA-N, WIGIZIANZCJQQY-UHFFFAOYSA-N, HMS1570C03, HMS2052L03, HMS2090K18, HMS2097C03, HMS2235L07, HMS3269A09, HMS3372O07, HMS3394L03, HMS3654F17, HMS3677K06, HMS3714C03, Pharmakon1600-01504915, ZINC537791, BCP05331, HY-B0104, Tox21_110713, AC-476, NSC759809, s1344, STL451059, STL453194, AKOS015894919, AKOS015969663, Glimepiride, >=98% (HPLC), solid, Tox21_110713_1, ZINC100001976, ZINC100070954, AB07644, AN-1036, AT-6093, BCP9000728, CCG-101156, CS-1844, DB00222, KS-5238, NC00406, NSC-759809, NCGC00016960-01, NCGC00016960-02, NCGC00016960-04, NCGC00016960-05, NCGC00016960-07, NCGC00161404-01, NCGC00161404-02, NCGC00181757-01, NCGC00371061-06, 1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea, 3-ethyl-4-methyl-n-(4-(n-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro, AK164454, BC204710, SAM001246710, SC-13775, SC-46287, SMR001550123, AB0073063, LS-136752, TL8005924, TX-017626, AB00513874, FT-0626713, FT-0668978, FT-0696605, G0395, SW196369-4, C07669, D00593, 46931-EP2269989A1, 46931-EP2270011A1, 46931-EP2272825A2, 46931-EP2272841A1, 46931-EP2275414A1, 46931-EP2287165A2, 46931-EP2287166A2, 46931-EP2292620A2, 46931-EP2295406A1, 46931-EP2295422A2, 46931-EP2298769A1, 46931-EP2298772A1, 46931-EP2298776A1, 46931-EP2301936A1, 46931-EP2305648A1, 46931-EP2308839A1, 46931-EP2308847A1, 46931-EP2308878A2, 46931-EP2311822A1, AB00513874-06, AB00513874-08, AB00513874-09, AB00513874_10, AB00513874_11, 479G971, I06-0029, Q-201158, SR-05000001508-1, SR-05000001508-2, SR-05000001508-3, BRD-K34776109-001-03-4, BRD-K42693031-001-01-8, Glimepiride, British Pharmacopoeia (BP) Reference Standard, Glimepiride, European Pharmacopoeia (EP) Reference Standard, 3-ethyl-4-methyl-N-(4-(N-((1r,4r)-4-methylcyclohexylcarbamoyl), Glimepiride, United States Pharmacopeia (USP) Reference Standard, sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, Glimepiride for system suitability, European Pharmacopoeia (EP) Reference Standard, 1-[[4-[2-[[(3-Ethyl-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]-3-(cis-4-methylcyclohexyl)urea (cis-Glimepiride), 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-2-oxo-N-(2-{4-[({[(1r,4r)-4-methylcyclohexyl]carbamoyl}amino)sulfonyl]phenyl}ethyl)-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-(4-(N-(((1r,4r)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ETHYL-4-METHYL-N-(4-(N-((1R,4R)-4-METHYLCYCLOHEXYLCARBAMOYL)SULFAMOYL)PHENETHYL)-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE, 3-ethyl-4-methyl-N-(4-(N-((4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-(4-(N-((trans-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-[2-(4-{[(4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-Ethyl-4-methyl-N-[2-[4-[[3-(4-methylcyclohexyl)ureido]sulfonyl]phenyl]ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, 3-ethyl-4-methyl-N-{2-[4-({[(4-methylcyclohexyl)carbamoyl]amino}sulfonyl)phenyl]ethyl}-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide, cis-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(cis-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide, N'-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-N-(4-methylcyclohexyl)carbamimidic acid, N-[4-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)-ethyl]-benzenesulfonyl]-N'-4-methylcyclohexylurea, trans-1-(4-(2-(3-ethyl-4-Me-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenylsulfonyl)-3-(4-methylcyclohexyl)urea, trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide, Trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide, trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxyamide, Avandaryl, Duetact, diameprid, glimax, glirid, glymepiride, vitamine, Mixture Name, TOCOPHEROL, Glimepirida Parke-Davis, Glimepiride EP Impurity A, D0B2GI, C24H34N4O5S, Glimepiride (JAN/USP/INN), Glimepiride [USAN:INN:BAN], Amaryl, Glista OD, Glimepiride, CID3476, C24-H34-N4-O5-S, ACN-048752, CS-O-30930, A4033, 64598P, A10430, C057619, 1406-18-4, 1-(4-(2-(3-ethyl-4-methyl-2-oxo-3-pyrrolinecarboxamido)ethyl)phenylsulfonyl)-3-(4-methylcyclohexyl)urea, 1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-, GMR,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited